- Home
- PTGX vs EVCM Comparison
PTGX vs EVCM Comparison
Compare PTGX & EVCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PTGX | EVCM |
|---|---|---|
| Founded | 2006 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.2B | 2.1B |
| IPO Year | 2016 | 2021 |
Fundamental Metrics
Financial Performance| Metric | PTGX | EVCM |
|---|---|---|
| Price | $103.02 | $11.60 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 12 | 7 |
| Target Price | ★ $106.67 | $10.67 |
| AVG Volume (30 Days) | ★ 807.6K | 142.6K |
| Earning Date | 05-05-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 145.45 |
| EPS | N/A | ★ 0.10 |
| Revenue | N/A | ★ $588,907,000.00 |
| Revenue This Year | $867.86 | $7.39 |
| Revenue Next Year | N/A | $5.84 |
| P/E Ratio | ★ N/A | $116.80 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $39.60 | $7.66 |
| 52 Week High | $107.84 | $14.41 |
Technical Indicators
Market Signals| Indicator | PTGX | EVCM |
|---|---|---|
| Relative Strength Index (RSI) | 62.28 | 55.17 |
| Support Level | $76.63 | $10.78 |
| Resistance Level | N/A | $12.01 |
| Average True Range (ATR) | 4.88 | 0.65 |
| MACD | 0.13 | 0.08 |
| Stochastic Oscillator | 76.48 | 84.65 |
Price Performance
Historical ComparisonAbout PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.
About EVCM EverCommerce Inc.
EverCommerce Inc provides tailored Software-as-a-Service solutions for service-based small- and medium-sized businesses (SMBs) in-home services, health services, and fitness & wellness. The Company served more than 745,000 customers across three core verticals: EverPro for Home Services; EverHealth for Health Services; and EverWell for Wellness Services. Revenue is mostly generated from the United States. Operating in a single segment, their vertically-tailored SaaS offerings cater to SMBs' specialized demands, enabling them to automate processes, generate business, and enhance customer loyalty.